A Aqemia
Updates & Highlights
Recent Openings
View all 1 jobs arrow_forwardAll Jobs
Culture & Mission
Benefits & Perks
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Competitive Salary
Market-rate compensation
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Aqemia?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentAqemia
Aqemia
The Pharma Letter · 5 months ago
Aqemia’s differentiated discovery platform creates ‘bright future ahead’
Aqemia’s differentiated discovery platform creates ‘bright future ahead’
The Pharma Letter · 5 months ago
Aqemia bets physics-driven AI can deliver novel drugs, not faster me-too molecules
Aqemia bets physics-driven AI can deliver novel drugs, not faster me-too molecules
drugdiscoverytrends.com · 5 months ago
Aqemia to Attend the 44th Annual J.P. Morgan Healthcare Conference 2026
Aqemia to Attend the 44th Annual J.P. Morgan Healthcare Conference 2026
Business Wire · 7 months ago
Aqemia to Participate in the Jefferies Global Healthcare Conference 2025
Aqemia to Participate in the Jefferies Global Healthcare Conference 2025
Business Wire · 7 months ago
From physics to pharma: How Aqemia is reinventing the future of medicines
From physics to pharma: How Aqemia is reinventing the future of medicines
pharmaphorum · 7 months ago
Aqemia to Participate in Jefferies European Disruptive Tech Conference
Aqemia to Participate in Jefferies European Disruptive Tech Conference
Press Release Hub · 9 months ago
Biotech Aqemia secures €7M grant for drug discovery using deep physics
Biotech Aqemia secures €7M grant for drug discovery using deep physics
Tech.eu · about 1 year ago
Aqemia: $7.4 Million Grant Secured To Advance Epitranscriptomics Programs
Aqemia: $7.4 Million Grant Secured To Advance Epitranscriptomics Programs
Pulse 2.0 · about 1 year ago
Paris-based Aqemia receives $7.4M to pioneer RNA-based drug discovery
Paris-based Aqemia receives $7.4M to pioneer RNA-based drug discovery
Tech Funding News · about 1 year ago
Aqemia Advances Epitranscriptomics Programs and Expands into Small-Molecule RNA Targeting with $7.4 Million Grant
Aqemia Advances Epitranscriptomics Programs and Expands into Small-Molecule RNA Targeting with $7.4 Million Grant
Business Wire · about 1 year ago
Aqemia raises €30 million to accelerate large-scale drug discovery
Aqemia raises €30 million to accelerate large-scale drug discovery
ActuIA · over 1 year ago
Dentons Paris advises Bpifrance Large Venture in the new funding round of Aqemia
Dentons Paris advises Bpifrance Large Venture in the new funding round of Aqemia
Dentons · over 1 year ago
London calling: Paris-based AQEMIA secures €94.9 million to expand to the UK and accelerates molecular research
London calling: Paris-based AQEMIA secures €94.9 million to expand to the UK and accelerates molecular research
EU-Startups · over 1 year ago
AQEMIA raises an additional $38M for an AI-powered drug discovery platform, reaching total funding of $100M
AQEMIA raises an additional $38M for an AI-powered drug discovery platform, reaching total funding of $100M
Tech Funding News · over 1 year ago
Aqemia raises $38M to find new drugs by meshing theoretical physics with GenAI
Aqemia raises $38M to find new drugs by meshing theoretical physics with GenAI
TechCrunch · over 1 year ago
AQEMIA Hits $100 Million Funding Milestone, Paving Way to Clinical Trials and Global Expansion Starting with London, UK
AQEMIA Hits $100 Million Funding Milestone, Paving Way to Clinical Trials and Global Expansion Starting with London, UK
Cathay Capital · over 1 year ago
Partner Spotlight: AQEMIA and Sanofi Harness Generative AI and Deep Physics to Power R&D
Partner Spotlight: AQEMIA and Sanofi Harness Generative AI and Deep Physics to Power R&D
Sanofi · over 1 year ago
AQEMIA Achieves Research Milestone Against Undruggable Target in Immuno-Oncology with Servier
AQEMIA Achieves Research Milestone Against Undruggable Target in Immuno-Oncology with Servier
Business Wire · almost 2 years ago
5 things to know about Paris-based Aqemia using Gen AI and quantum to design new drugs and has raised €60M
5 things to know about Paris-based Aqemia using Gen AI and quantum to design new drugs and has raised €60M
Tech Funding News · over 2 years ago